MENU
+Compare
ACRS
Stock ticker: NASDAQ
AS OF
Jul 21, 04:59 PM (EDT)
Price
$1.64
Change
+$0.02 (+1.24%)
Capitalization
174.33M

ACRS Aclaris Therapeutics Forecast, Technical & Fundamental Analysis

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States... Show more

ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ACRS with price predictions
Jul 18, 2025

ACRS in downward trend: price may drop because broke its higher Bollinger Band on June 25, 2025

ACRS broke above its upper Bollinger Band on June 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 41 similar instances where the stock broke above the upper band. In of the 41 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where ACRS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACRS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 11, 2025. You may want to consider a long position or call options on ACRS as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACRS just turned positive on July 10, 2025. Looking at past instances where ACRS's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACRS advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 196 cases where ACRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.210) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). ACRS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (8.163) is also within normal values, averaging (270.975).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACRS is expected to report earnings to rise 15.75% to -13 cents per share on August 06

Aclaris Therapeutics ACRS Stock Earnings Reports
Q2'25
Est.
$-0.14
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.72
Q3'24
Missed
by $0.10
Q2'24
Beat
by $0.05
The last earnings report on May 08 showed earnings per share of -11 cents, beating the estimate of -14 cents. With 598.37K shares outstanding, the current market capitalization sits at 174.33M.
A.I. Advisor
published General Information

General Information

a manufacturer of novel dermatological therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
701 Lee Road
Phone
+1 484 324-7933
Employees
91
Web
https://www.aclaristx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASNCF0.24N/A
N/A
A Sonic Aerospace, Ltd.
MGHL1.21N/A
N/A
Morgan Group Holding Co.
PEFDF0.64N/A
N/A
DELFI LTD
FQVLF17.04-0.14
-0.82%
First Quantum Minerals Ltd.
PHJMF0.04N/A
-5.29%
PT Hanjaya Mandala Sampoerna Terbuka

ACRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with MYNZ. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then MYNZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
+1.26%
MYNZ - ACRS
40%
Loosely correlated
+2.72%
ARCT - ACRS
34%
Loosely correlated
-0.30%
IBRX - ACRS
34%
Loosely correlated
-2.83%
RXRX - ACRS
32%
Poorly correlated
+5.80%
PDSB - ACRS
32%
Poorly correlated
-4.17%
More